A Clinical Study Evaluating the Safety and Efficacy of IDP-115 in Patients With Rosacea

Completed · Phase 2

Conditions studied: Rosacea

In brief

The purpose of this study is to assess the safety and effectiveness of IDP-115 in treating patients with rosacea.

Key facts

Study ID

NCT00667173

Run by

Dow Pharmaceutical Sciences

People needed

140

Starts

2007-11-01

Expected to finish

2008-07-01

Last updated by the study team

2012-02-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Presence of facial rosacea
• Presence of inflammatory lesions

You may not qualify if…

• Dermatological conditions of the face that could interfere with clinical evaluations
• Known history of photosensitivity disorders (such as lupus erythematosus or polymorphous light eruption)
• Female subjects who are pregnant, nursing, planning a pregnancy, or become pregnant during the study

Where it is running

• Medical Affiliated Research Center, Inc. — Huntsville, Alabama, United States
• Therapeutics Clinical Research — San Diego, California, United States
• Solano Clinical Research — Vallejo, California, United States
• Cherry Creek Dermatology Research Inc. — Denver, Colorado, United States
• FXM Research Corp. — Miami, Florida, United States
• MedaPhase Inc. — Newnan, Georgia, United States
• Henry Ford Medical Center — Detroit, Michigan, United States
• Academic Dermatology Associates — Albuquerque, New Mexico, United States
• University Dermatology Consultants, Inc. — Cincinnati, Ohio, United States
• DermResearch, Inc. — Austin, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.